Boundless Bio, Inc.
For the period ended Mar 31, 2026. Filed May 8, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 8, 2026
BOLD$2.46+2.1%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
(in thousands, except par value data)
| March 31, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $17,483 | $17,868 |
| Short-term investments | 75,364 | 89,713 |
| Prepaid expenses and other current assets | 1,769 | 2,030 |
| Total current assets | 94,616 | 109,611 |
| Property and equipment, net | 2,940 | 3,216 |
| Right-of-use asset, net | 42,831 | 43,659 |
| Restricted cash | 560 | 560 |
| Other assets | 23 | 13 |
| Total assets | $140,970 | $157,059 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities | $5,710 | $6,727 |
| Accrued compensation | 589 | 2,643 |
| Lease liabilities, current portion | 3,284 | 3,167 |
| Total current liabilities | 9,583 | 12,537 |
| Lease liabilities, non-current | 45,004 | 45,868 |
| Total liabilities | 54,587 | 58,405 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 70,000 shares authorized and no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 700,000 shares authorized, 22,407 shares issued and outstanding as of March 31, 2026; 700,000 shares authorized, 22,407 shares issued and outstanding as of December 31, 2025 | 2 | 2 |
| Additional paid-in-capital | 359,628 | 358,257 |
| Accumulated other comprehensive income (loss) | (23) | 64 |
| Accumulated deficit | (273,224) | (259,669) |
| Total stockholders’ equity | 86,383 | 98,654 |
| Total liabilities and stockholders’ equity | $140,970 | $157,059 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.